Stocks Mentioned in this article:
Johnson and Johnson (JNJ)
Eli Lilly and Co. (LLY)
Merck (MRK)
Pfizer (PFE)
EARNINGS PREVIEW: US Drug Makers May Report Lower 3Q Profit
By Nathan Becker, Of DOW JONES NEWSWIRES
TAKING THE PULSE: Analysts expect most major U.S. drug makers to post third- quarter earnings slightly lower than those a year earlier, as sales of several big-name drugs have declined recently after some consumers cut back on health- care costs. Health-care reform and European national health programs imposing price cuts on drugs also offer added pressure for companies. Results in recent quarters have been skewed by big acquisitions, either boosting companies' revenue or sagging their bottom lines because of charges. Several of the industry bigwigs have also been subject to downbeat credit-ratings news because of recent problems with supply and pipeline issues, as well as upcoming patent expiry.
COMPANIES TO WATCH:
Showing posts with label Earnings Preview 3Q. Show all posts
Showing posts with label Earnings Preview 3Q. Show all posts
Subscribe to:
Posts (Atom)